Eisai shares rose sharply Thursday morning after the U.S. Food and Drug Administration’s review memo on Leqembi raised expectations for full approval of the Alzheimer’s drug.
Roodeweg 222, Willemstad, Curaçao
Eisai shares rose sharply Thursday morning after the U.S. Food and Drug Administration’s review memo on Leqembi raised expectations for full approval of the Alzheimer’s drug.
Roodeweg 222, Willemstad, Curaçao